AI may be ready for clinical supply, but the systems behind it are not. Five barriers show why better models alone will not fix forecasting or waste.
- Lessons In Forecasting Discipline From A $40B Supply Chain
- Clinical Supply When There's No Drug To Ship
- Why Clinical Supply Problems Rarely Start In Clinical Supply
- The Last Mile Nobody Talks About: What Really Happens To Unused Clinical Trial Supplies
- AI In Clinical Supply: From Forecasting To Execution Decisions
- Accountability Gaps Can Break Clinical Supply Contracts
- When Clinical Supply Becomes A Clinical Decision
- How To Build Clinical Supply Into Drug Development From The Start
ON-DEMAND WEBINARS
This webinar presents the ultimate guide to scenario planning through modern technology as a way to inform clinical supply decisions.
Investigational products present a distinctly high-risk environment for labeling and barcoding. Explore best practices for barcoding solutions that allow for improved medication safety in clinical trials.
Explore the opportunities to optimize your supply chain strategy and facilitate direct-to-site, direct-to-patient and hybrid services utilizing a global GMP depot network.
Discover how flexible, site-focused monitoring strategies are transforming clinical trials by improving communication, enhancing compliance, and resolving challenges before they impact study success.
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
![iStock-899483138 lab freeze cold 450x300.jpg]( "When Every Hour Counts: Emergency Transfer Protects Critical Biomedical Materials")
When Every Hour Counts: Emergency Transfer Protects Critical Biomedical MaterialsRapid deployment of specialized cold chain logistics and cryogenic assets ensures strict temperature compliance, protecting critical research continuity and preventing catastrophic material loss.
-
![Scientist research laboratory pipette GettyImages-487041629]( "Overcoming The Complex Logistics Of Autologous Cell Therapy Trials: A Deep Dive Into Challenges And Solutions")
Overcoming The Complex Logistics Of Autologous Cell Therapy Trials: A Deep Dive Into Challenges And SolutionsExplore critical logistical requirements in autologous cell therapies logistics and learn how to overcome challenges and achieve successful and timely autologous cell therapy trials.
-
![West Pharma]( "Key Considerations For Packaging Solutions For Cell And Gene Therapies")
Key Considerations For Packaging Solutions For Cell And Gene TherapiesThinking of packaging and delivery factors early and often will minimize risks to the safety and efficacy of your cell and gene therapy drug product from the bench to the patient.
-
![trends-for-2025-GettyImages-2161094939]( "Outlook 2025: Key Trends & Insights")
Outlook 2025: Key Trends & InsightsDive into the key trends and challenges shaping the year ahead, from geopolitical uncertainties to cutting-edge innovation in AI, oncology, and weight-loss therapies.
-
![Trial Design]( "When Protocol Amendments Meet RTSM: From Headache To High-Performance")
When Protocol Amendments Meet RTSM: From Headache To High-PerformanceLearn why an RTSM solution should be adaptive and flexible, and should help clinical trial teams uncover the best ways to handle protocol amendments.
-
![Laptop clinical trials iStock-653839742]( "What Are Decentralized Clinical Trials (DCTs)?")
What Are Decentralized Clinical Trials (DCTs)?Discover how DCTs leverage “virtual” tools, such as telemedicine, sensory-based technologies, wearable medical devices, and direct delivery of study drugs and materials to patients’ homes.
-
![GettyImages-1156884561-fill-finish]( "Key Considerations For Selecting Flexible Fillers")
Key Considerations For Selecting Flexible FillersFlexible fillers are beneficial to drug developers looking for lifecycle management of their drug products. Explore key considerations for selecting flexible fill/finish manufacturing technologies.
-
![GettyImages-1293772957-scientist-laboratory-computer-drug-development]( "Five Key Trends In CMC")
Five Key Trends In CMCCMC is evolving with digitalization, sustainability, supply chain resilience, post-merger integration, and personalized medicine.
-
![GettyImages-1312767504 data health]( "Using IRT Data To Automate And Optimize Clinical Supply")
Using IRT Data To Automate And Optimize Clinical SupplyLearn how clinical teams can save between $150,000 and $1 million in annual drug and shipping costs through automated supply optimization.
-
![GettyImages-1398569507 regulatory]( "5 Ways To Get Ready For IRT Regulatory Inspections")
5 Ways To Get Ready For IRT Regulatory InspectionsPreparing for a regulatory inspection during a clinical trial can be daunting. Learn about the importance of clear roles, audit trails, data integrity, and training, and get recommendations to help.
- Can Your Operating Model Grow? Preparing Clinical Supply For What Comes Next
- The Biggest Early-Stage Clinical Supply Mistake? Building Too Much, Too Soon.
- How Clinical Supply Is Shaping The Next Generation Of Cell And Gene Therapies
- First Advisors In: Meet Clinical Supply Leader's Inaugural Board Members
CATALENT CORNER
| Insights from Catalent's Clinical Supply Experts |
SPONSORED CONTENT
Impact Of Supplier Choice On APAC Clinical Trial Execution
Learn about strategies Asia-Pacific has become an increasingly complex and congested destination for clinical trials as local and global sponsors alike flock to the region to take advantage of its many benefits, including access to large patient pools. Choosing the right clinical packaging and supply chain partner to support these studies is critical and can vary significantly based upon what countries are involved and the types of services required.
